Centrus Reports Third Quarter 2026 Results
• GAAP net income of $31.6 million compared to GAAP net income of $3.9 million in Q3 2025
• Non-GAAP adjusted net loss (1) of $9.4 million, compared to non-GAAP adjusted net income (1) of $5.2 million in Q3 2025
• Grew contingent Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU) enrichment backlog to $5.4 billion
• Completed manufacturing and began shipping centrifuges from Oak Ridge, Tennessee, ahead of year-end target
• Finalized contracts with all of the supply-chain deemed critical ahead of year-end target
BETHESDA, Md. - Centrus Energy Corp. (NYSE: LEU) (“Centrus” or the “Company”) today reported third quarter 2026 results. The Company reported net income of $31.6 million for the three months ended September 30, 2026, which is $1.53 (basic) and $1.41 (diluted) per common share. This translates to adjusted net loss (1) of $9.4 million for the three months ended September 30, 2026, which is adjusted EPS (1) loss of $0.46 (basic and diluted) per common share.
“The third quarter’s continued execution across all facets of our business primed Centrus to achieve a critical milestone: shipping the first new centrifuge to support our commercial-scale expansion,” said Centrus Energy President and CEO Amir Vexler.
“This achievement, along with us demonstrating that we have a complete manufacturing supply chain in place, was reached two months ahead of our ambitious schedule and puts us far ahead of the competition. And because that supply chain is unobligated, we are able to serve both the national security and commercial markets.”
“Furthermore, our recent acquisition of Westerman helps to derisk our build out and our overall business model. It will drive growth for both organizations through commercial and operational synergies while diversifying our business model. We are now focused on scaling up our supply chain as we begin manufacturing and shipping more centrifuges from Oak Ridge to Piketon.”
(1) A reconciliation of non-GAAP results are detailed in the Financial Results section. Additional information can be found in the materials on the Centrus investor relations website at https://investors.centrusenergy.com.
Centrus generated total revenue of $55.5 million and $74.9 million for the three months ended September 30, 2026 and 2025, respectively, a decrease of $19.4 million or 26%.
Revenue from the LEU segment was $31.8 million and $44.8 million for the three months ended September 30, 2026 and 2025, respectively, a decrease of $13.0 million or 29%. Uranium revenue decreased by $16.4 million quarter over quarter. The decrease in uranium sales is primarily attributable to a decrease in the volume of uranium sold. Separative work units (SWU) revenue increased by $3.4 million as a result of a 19% increase in the volume of SWU sold and a 10% increase in the average price of SWU sold.
Revenue from the Technical Solutions segment was $23.7 million and $30.1 million for the three months ended September 30, 2026 and 2025, respectively, a decrease of $6.4 million or 21%. The decrease in revenue was primarily attributable to a $10.2 million decrease in revenue generated by the HALEU production contract with the Department of Energy (“DOE”) signed in 2022 (“HALEU Operation Contract”), while the remaining change was related to other contracts.
Cost of sales for the LEU segment was $38.7 million and $52.6 million for the three months ended September 30, 2026 and 2025, respectively, a decrease of $13.9 million or 26%. Uranium costs decreased primarily as a result of a decrease in the volume of uranium sold. SWU costs increased as a result of a 28% increase in the average unit cost of SWU sold and a 19% increase in the volume of SWU sold.
Cost of sales for the Technical Solutions segment was $27.4 million and $26.6 million for the three months ended September 30, 2026 and 2025, respectively, an increase of $0.8 million or 3%. The increase was primarily attributable to an increase in costs related to customer contracts, partially offset by a $1.7 million decrease in costs incurred under the HALEU Operation Contract.
The Company recognized gross loss of $10.6 million and $4.3 million for the three months ended September 30, 2026 and 2025, respectively, an increase of $6.3 million or 147%.
Gross loss for the LEU segment was $6.9 million and $7.8 million for the three months ended September 30, 2026 and 2025, respectively, a decrease of $0.9 million or 12%. LEU customers generally have multi-year contracts that carry annual purchase commitments, not quarterly commitments. The gross loss in our LEU business varies based upon the timing of those contracts. The pricing applied to deliveries varies depending upon the market conditions at the time the contract was signed. The decrease for the three months ended September 30, 2026 was primarily due to the change in the composition of contracts quarter over quarter.
Gross margin for the Technical Solutions segment was a loss of $3.7 million and profit of $3.5 million for the three months ended September 30, 2026 and 2025, respectively, a decrease of $7.2 million or 206%. The decrease was primarily attributable to the HALEU Operation Contract.
Net income was $31.6 million and $3.9 million for the three months ended September 30, 2026 and 2025, respectively, an increase of $27.7 million or 710%. The increase was primarily driven by a $46.4 million gain recognized from the fair value adjustment of warrant liabilities during the current period and an increase of $4.0 million in investment income. The increase was partially offset by a $9.0 million decrease in income tax benefit and a $6.3 million increase in gross loss, a $3.7 million increase in selling, general and administrative expenses, and a $3.0 million increase in advanced technology costs.
The Company’s backlog across both segments is $7.0 billion as of September 30, 2026 and extends to 2040. Our LEU segment backlog as of September 30, 2026 is approximately $6.2 billion. The LEU backlog is the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries primarily under medium and long-term contracts with fixed commitments and approximately $5.4 billion in contingent LEU and HALEU sales commitments, $5.1 billion of which are under definitive agreements, in support of potential construction of LEU and HALEU production capacity at the Piketon, Ohio facility. The contingent sales commitments tend to relate to achievement of operational milestones. Our Technical Solutions segment backlog is approximately $0.8 billion as of September 30, 2026, and includes both funded amounts (services for which funding has been both authorized and appropriated by the customer), unfunded amounts (services for which funding has not been appropriated), and unexercised options. The current DOE budget proposed for fiscal year 2027 does not include further funding for the operation of the HALEU cascade under the HALEU Operation Contract, which represents approximately $0.8 billion of the Technical Solutions backlog as of September 30, 2026. Separately, DOE has communicated that it does not currently intend to exercise further options under the HALEU Operation Contract.
The Company is updating some of its financial and operational guidance for the full year 2026 based on information available to the Company at the time of this release. This includes Centrus having:
• finalized contracts with all of the supply-chain deemed critical ahead of year-end target; and
• completed the first certified-for-construction package ahead of year-end target.
• Total capital deployment to be in the range of $350 million to $500 million, driven by increased investment in the Company’s industrial build out related to its centrifuge manufacturing
• Hire at least 175 net new employees for its Piketon, Ohio, facility up from 100 net new employee hires
The Company’s 2026 guidance is subject to a number of assumptions and uncertainties that could affect results either positively or negatively. Variations from these expectations could cause differences between this guidance and the ultimate results. This includes the assumption of no significant change in restrictions in our ability to receive and sell Russian LEU or other uranium products, no significant economic disruptions or downturns, the successful implementation of our planned expansion projects, and that current business operations will continue on an ongoing basis.
Centrus Energy is a trusted American supplier of nuclear fuel and services for the nuclear power industry, helping meet the growing need for clean, affordable, carbon-free energy. Since 1998, the Company has provided its utility customers with more than 1,850 reactor years of fuel, which is equivalent to more than 7 billion tons of coal.
With world-class technical and engineering capabilities, Centrus is pioneering production of High-Assay, Low-Enriched Uranium and is leading the effort to restore America’s uranium enrichment capabilities at scale so that we can meet our clean energy, energy security, and national security needs. Find out more at www.centrusenergy.com or follow us on LinkedIn and X.
This news release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “will”, “should”, “could”, “would” or “may” and other words of similar meaning. These forward- looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions with respect to future events and operational, economic and financial performance. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks, uncertainties and other factors, which may be beyond our control and which may be exacerbated by any worsening of the global business and economic environment including but not limited to, risks and uncertainties related to the following:
• our ability to obtain a long-term extension of our existing lease for Piketon from the DOE on acceptable terms or at all, including the potential need to delay, scale back, or abandon our planned expansion of LEU and HALEU enrichment capacity in Piketon and to recognize a significant non-cash charge relating to capitalized improvements at Piketon;
• the war in Ukraine and other geopolitical conflicts, including the resulting bans, laws, tariffs, sanctions or other government measures, and actions by third parties, including contractual counterparties, as a result of such conflicts that could directly or indirectly impact our ability to obtain, deliver, transport, sell or collect payment for, LEU or the SWU and natural uranium hexafluoride components of LEU;
• our reliance on third-party suppliers to provide essential products and services to us;
• restrictions on imports and exports, including those imposed under the RSA, and related to international trade legislation;
• our government contracts, including related to government shutdowns, changes to the U.S. government’s appropriated funding levels for HALEU and the government’s inability to satisfy its obligations;
• our receipt of additional task orders under the HALEU Production Contract, LEU Production Contract and HALEU Deconversion Contract and, if awarded, the nature, timing and amount thereof;
• our ability to obtain new contracts or funding to be able to continue operations;
• whether or when government demand for HALEU or LEU for government or commercial uses will materialize and at what level;
• the impact and potential extended duration of a supply/demand imbalance in the market for LEU;
• significant competition from major LEU producers, including foreign competitors, who may be less cost sensitive than we are;
• pricing trends and demand in the uranium and enrichment markets, especially in light of the potential of limited supply and our dependence on others for deliveries of LEU;
• our ability to successfully implement our planned expansion projects in Piketon, Ohio and Oak Ridge, Tennessee, including our ability to raise the capital necessary for such projects;
• our ability to successfully integrate artificial intelligence technologies into our operations;
• our ability to realize the anticipated benefits of acquisitions, including our acquisition of Westerman, and risks associated with acquisitions, including integration difficulties, unknown liabilities, additional costs and dilution;
• the fact that our revenue is largely dependent on our largest customers and our sales backlog;
• our long-term liabilities, including our postretirement health and life benefit obligations, our 0% Convertible Notes and our 2.25% Convertible Notes;
• failures or security, including cybersecurity, breaches of our information technology systems; and
• the impact of, or changes to, government regulation and policies or interpretation of laws or regulations, including by the SEC, DOE, DOC and the NRC.
Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various disclosures made in this news release and in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025, under Part II, Item 1A - “Risk Factors” in our Quarterly report on Form 10-Q for the quarter ended March 31, 2026, under Part II, Item 1A - “Risk Factors” in our Quarterly report on Form 10-Q for the quarter ended June 30, 2026, and the Risk Factors in our Form S-3 Shelf Registration filed with the SEC on November 2, 2026, and our filings with the SEC that attempt to advise interested parties of the risks and factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
NON-GAAP ADJUSTED OPERATING (LOSS) INCOME, ADJUSTED NET INCOME (LOSS) AND ADJUSTED NET INCOME (LOSS) PER SHARE RECONCILIATION TABLE
The Company measures Operating (Loss) Income, Net Income and Net Income per Share on a GAAP basis, on a normalized basis (“Normalized Operating (Loss) Income”, “Normalized Net Income (Loss)” and “Normalized Net Income (Loss) per Share”), and on an adjusted basis (“Adjusted Operating (Loss) Income”, “Adjusted Net Income (Loss)” and “Adjusted Net Income (Loss) per Share”) to exclude (i) the gain on the change of fair value of the warrant liability, (ii) short-term, non-capitalizable costs related to the expansion of our operations in Piketon, Ohio and Oak Ridge, Tennessee to scale up uranium enrichment operations (“Growth Costs”) and (iii) stock-based compensation.
Normalized earnings exclude the revaluation of the Warrant Liability , which is included as Gain on Change in Fair Value of Warrant Valuation on the Condensed Consolidated Statements of Operations and Comprehensive Income. We are also adjusting for the one-time expenses related to the issuance of the warrants, which were included as Selling, General and Administrative expense on the Condensed Consolidated Statements of Operations and Comprehensive Income.
Adjusted earnings further exclude Growth Costs and stock-based compensation. Growth Costs relate to the initial phase of our expansion projects (e.g. manufacturing readiness and the training and onboarding of new employees) and are included as Advanced Technology Costs on the Condensed Consolidated Statements of Operations and Comprehensive Income. The Company expects to stop expensing Growth Costs as costs related to our expansion projects become capitalizable. We incur expense related to stock-based compensation which are included as Selling, General and Administrative expense on the Condensed Consolidated Statements of Operations and Comprehensive Income.
We believe Adjusted Operating (Loss) Income, Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share, which are non-GAAP financial measures, provide investors with additional understanding of the Company’s overall financial performance as well as its strategic financial planning analysis and period-to-period comparability. These metrics are useful to investors because they reflect how management evaluates the Company’s ongoing operating performance from period-to-period after removing certain transactions and activities that affect comparability of the metrics and are not reflective of the Company’s core operations.
Our calculation of Adjusted Operating (Loss) Income, Adjusted Net Income, and Adjusted Net Income per Share may not be comparable to similarly named measures reported by other companies.
The following tables present a reconciliation of the Operating (Loss) Income, the most directly comparable GAAP measure, to Adjusted Operating (Loss) Income, a reconciliation of the Net Income, the most directly comparable GAAP measure, to Adjusted Net Income, and a reconciliation of the Net Income Per Share, the most directly comparable GAAP measure, to Adjusted Net Income Per Share, for each of the periods indicated:
Three Months Ended September 30, 2026 Compared with Three Months Ended September 30, 2025
Nine Months Ended September 30, 2026 Compared with Nine Months Ended September 30, 2025
Nine Months Ended September 30, OPERATING 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 58.4 $ 60.0 Adjustments to reconcile net income to cash used in operating activities: Depreciation and 6.8 6.9 amortization Gain on change in fair value of warrant -46.4 — liability Deferred tax assets 4.2 3.6 Equity-related 16.8 5.3 compensation Revaluation of -0.6 4.1 inventory borrowings Gain on extinguishment — -11.8 of 8.25% Notes Amortization of debt issuance costs and 4.0 — discount Other reconciling 0.3 2.1 adjustments, net Changes in operating assets and liabilities: Accounts receivable 3.9 19.2 Inventories 106.9 -317.2 Inventories owed to customers and -138.7 222.8 suppliers Other current assets 0.3 0.2 Accounts payable and -8.1 -4.5 other liabilities Payables under inventory purchase 23.3 126.4 agreements Deferred revenue and advances from -37.4 -12.5 customers, net of deferred costs Pension and postretirement benefit -4.5 -4.9 liabilities Other changes, net -0.3 -0.3 Cash (used in) provided by operating -11.1 99.4 activities INVESTING Capital expenditures -226.4 -10.1 Cash used in investing -226.4 -10.1 activities FINANCING Proceeds from the issuance of common 53.9 139.7 stock, net Proceeds from the issuance of 0% — 782.4 Convertible Senior Notes, net Proceeds from the issuance of common stock, pre-funded 493.8 — warrants, and common warrants, net Common stock withheld for tax obligations under -0.7 -2.9 stock-based compensation plan Payment of interest — -3.5 classified as debt Payment of principal to redeem 8.25% — -74.3 Notes Cash provided by 547.0 841.4 financing activities Effect of exchange rate changes on cash, -0.2 -0.1 cash equivalents and restricted cash Increase in cash, cash equivalents and 309.3 930.6 restricted cash Cash, cash equivalents and restricted 1,960.1 704.0 cash, beginning of period Cash, cash equivalents and restricted $ 2,269.4 $ 1,634.6 cash, end of period
Nine Months Ended September Supplemental cash flow 30, disclosures: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Cash paid for interest $ 4.5 $ 4.4 Cash paid for income taxes Federal $ — $ — State $ 0.4 $ 0.4 Foreign $ — $ — Non-cash activities: Adjustment of right to use lease assets $ 0.5 $ 1.3 from lease modification Property, plant and equipment included in accounts payable and $ 60.2 $ 2.2 accrued liabilities Equity issuance costs included in $ 0.4 $ — accounts payable and accrued liabilities Reclassification of equity-based $ 0.8 $ — compensation from equity to liability
September 30, December 31, 2026 2025 ────────────────────────────────────────────────────────────────────────────── ASSETS Current assets: Cash and cash equivalents $ 2,236.1 $ 1,957.2 Accounts receivable 26.8 30.7 Inventories 177.7 322.9 Deferred costs associated with deferred 33.2 40.9 revenue Other current assets 11.7 11.9 Total current assets 2,485.5 2,363.6 Property, plant and equipment, net of accumulated depreciation of $7.9 million 312.9 29.5 and $6.7 million as of September 30, 2026 and December 31, 2025, respectively Deposits for financial assurance 33.1 2.7 Intangible assets, net 15.7 21.2 Deferred tax assets 17.7 21.9 Other long-term assets 6.7 7.0 Total assets $ 2,871.6 $ 2,445.9 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued $ 107.6 $ 41.6 liabilities Payables under inventory purchase 41.8 18.5 agreements Inventories owed to customers and 54.0 192.7 suppliers Deferred revenue and advances from 85.3 131.1 customers, current Short-term inventory loans — 38.9 Current debt — — Total current liabilities 288.7 422.8 Long-term debt 1,178.8 1,174.8 Warrant liability 220.4 — Postretirement health and life benefit 68.1 72.2 obligations Pension benefit liabilities 2.9 3.0 Deferred revenue and advances from 0.7 — customers, noncurrent Other long-term liabilities 6.9 8.0 Total liabilities 1,766.5 1,680.8 Stockholders’ equity: Preferred stock, par value $1.00 per share, 20,000,000 shares authorized Series A Participating Cumulative — — Preferred Stock, none issued Class A Common Stock, par value $0.10 per share, 70,000,000 shares authorized, 19,733,908 and 18,945,365 shares 2.0 1.9 issued and outstanding as of September 30, 2026 and December 31, 2025, respectively Class B Common Stock, par value $0.10 per share, 30,000,000 shares authorized, 719,200 shares issued and outstanding 0.1 0.1 as of September 30, 2026 and December 31, 2025, respectively Excess of capital over par value 1,044.0 762.3 Retained earnings 59.9 1.5 Accumulated other comprehensive loss -0.9 -0.7 Total stockholders’ equity 1,105.1 765.1 Total liabilities and stockholders’ $ 2,871.6 $ 2,445.9 equity
Full text with the tables
EXHIBIT 99.1
FOR IMMEDIATE RELEASE:
November 4, 2026
Centrus Reports Third Quarter 2026 Results
• Revenue of $55.5 million, compared to revenue of $74.9 million in Q3 2025
• GAAP net income of $31.6 million compared to GAAP net income of $3.9 million
in Q3 2025
• Non-GAAP adjusted net loss (1) of $9.4 million, compared to non-GAAP adjusted
net income (1) of $5.2 million in Q3 2025
• Grew contingent Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium
(HALEU) enrichment backlog to $5.4 billion
• Enriching HALEU for the commercial market from existing 16-centrifuge cascade
• Completed manufacturing and began shipping centrifuges from Oak Ridge,
Tennessee, ahead of year-end target
• Finalized contracts with all of the supply-chain deemed critical ahead of
year-end target
• Completed first certified-for-construction package ahead of year-end target
BETHESDA, Md. - Centrus Energy Corp. (NYSE: LEU) (“Centrus” or the “Company”)
today reported third quarter 2026 results. The Company reported net income of
$31.6 million for the three months ended September 30, 2026, which is $1.53
(basic) and $1.41 (diluted) per common share. This translates to adjusted net
loss (1) of $9.4 million for the three months ended September 30, 2026, which is
adjusted EPS (1) loss of $0.46 (basic and diluted) per common share.
“The third quarter’s continued execution across all facets of our business
primed Centrus to achieve a critical milestone: shipping the first new
centrifuge to support our commercial-scale expansion,” said Centrus Energy
President and CEO Amir Vexler.
“This achievement, along with us demonstrating that we have a complete
manufacturing supply chain in place, was reached two months ahead of our
ambitious schedule and puts us far ahead of the competition. And because that
supply chain is unobligated, we are able to serve both the national security and
commercial markets.”
“Furthermore, our recent acquisition of Westerman helps to derisk our build out
and our overall business model. It will drive growth for both organizations
through commercial and operational synergies while diversifying our business
model. We are now focused on scaling up our supply chain as we begin
manufacturing and shipping more centrifuges from Oak Ridge to Piketon.”
(1) A reconciliation of non-GAAP results are detailed in the Financial Results
section. Additional information can be found in the materials on the Centrus
investor relations website at https://investors.centrusenergy.com.
Financial Results
Centrus generated total revenue of $55.5 million and $74.9 million for the three
months ended September 30, 2026 and 2025, respectively, a decrease of $19.4
million or 26%.
Revenue from the LEU segment was $31.8 million and $44.8 million for the three
months ended September 30, 2026 and 2025, respectively, a decrease of $13.0
million or 29%. Uranium revenue decreased by $16.4 million quarter over quarter.
The decrease in uranium sales is primarily attributable to a decrease in the
volume of uranium sold. Separative work units (SWU) revenue increased by $3.4
million as a result of a 19% increase in the volume of SWU sold and a 10%
increase in the average price of SWU sold.
Revenue from the Technical Solutions segment was $23.7 million and $30.1 million
for the three months ended September 30, 2026 and 2025, respectively, a decrease
of $6.4 million or 21%. The decrease in revenue was primarily attributable to a
$10.2 million decrease in revenue generated by the HALEU production contract
with the Department of Energy (“DOE”) signed in 2022 (“HALEU Operation
Contract”), while the remaining change was related to other contracts.
Cost of sales for the LEU segment was $38.7 million and $52.6 million for the
three months ended September 30, 2026 and 2025, respectively, a decrease of
$13.9 million or 26%. Uranium costs decreased primarily as a result of a
decrease in the volume of uranium sold. SWU costs increased as a result of a 28%
increase in the average unit cost of SWU sold and a 19% increase in the volume
of SWU sold.
Cost of sales for the Technical Solutions segment was $27.4 million and $26.6
million for the three months ended September 30, 2026 and 2025, respectively, an
increase of $0.8 million or 3%. The increase was primarily attributable to an
increase in costs related to customer contracts, partially offset by a $1.7
million decrease in costs incurred under the HALEU Operation Contract.
The Company recognized gross loss of $10.6 million and $4.3 million for the
three months ended September 30, 2026 and 2025, respectively, an increase of
$6.3 million or 147%.
Gross loss for the LEU segment was $6.9 million and $7.8 million for the three
months ended September 30, 2026 and 2025, respectively, a decrease of $0.9
million or 12%. LEU customers generally have multi-year contracts that carry
annual purchase commitments, not quarterly commitments. The gross loss in our
LEU business varies based upon the timing of those contracts. The pricing
applied to deliveries varies depending upon the market conditions at the time
the contract was signed. The decrease for the three months ended September 30,
2026 was primarily due to the change in the composition of contracts quarter
over quarter.
Gross margin for the Technical Solutions segment was a loss of $3.7 million and
profit of $3.5 million for the three months ended September 30, 2026 and 2025,
respectively, a decrease of $7.2 million or 206%. The decrease was primarily
attributable to the HALEU Operation Contract.
Net income was $31.6 million and $3.9 million for the three months ended
September 30, 2026 and 2025, respectively, an increase of $27.7 million or 710%.
The increase was primarily driven by a $46.4 million gain recognized from the
fair value adjustment of warrant liabilities during the current period and an
increase of $4.0 million in investment income. The increase was partially offset
by a $9.0 million decrease in income tax benefit and a $6.3 million increase in
gross loss, a $3.7 million increase in selling, general and administrative
expenses, and a $3.0 million increase in advanced technology costs.
Backlog
The Company’s backlog across both segments is $7.0 billion as of September 30,
2026 and extends to 2040. Our LEU segment backlog as of September 30, 2026 is
approximately $6.2 billion. The LEU backlog is the estimated aggregate dollar
amount of revenue for future SWU and uranium deliveries primarily under medium
and long-term contracts with fixed commitments and approximately $5.4 billion in
contingent LEU and HALEU sales commitments, $5.1 billion of which are under
definitive agreements, in support of potential construction of LEU and HALEU
production capacity at the Piketon, Ohio facility. The contingent sales
commitments tend to relate to achievement of operational milestones. Our
Technical Solutions segment backlog is approximately $0.8 billion as of
September 30, 2026, and includes both funded amounts (services for which funding
has been both authorized and appropriated by the customer), unfunded amounts
(services for which funding has not been appropriated), and unexercised options.
The current DOE budget proposed for fiscal year 2027 does not include further
funding for the operation of the HALEU cascade under the HALEU Operation
Contract, which represents approximately $0.8 billion of the Technical Solutions
backlog as of September 30, 2026. Separately, DOE has communicated that it does
not currently intend to exercise further options under the HALEU Operation
Contract.
2026 Outlook
The Company is updating some of its financial and operational guidance for the
full year 2026 based on information available to the Company at the time of this
release. This includes Centrus having:
• completed the manufacturing of its first centrifuge ahead of year-end target;
• finalized contracts with all of the supply-chain deemed critical ahead of
year-end target; and
• completed the first certified-for-construction package ahead of year-end
target.
Financial 2026 Outlook
For the full year 2026, on a consolidated basis, Centrus expects:
• Total revenue to be in the range of $450 million to $500 million
• Total capital deployment to be in the range of $350 million to $500 million,
driven by increased investment in the Company’s industrial build out related to
its centrifuge manufacturing
Operational 2026 Outlook
For the full year 2026, on a consolidated basis, Centrus expects to:
• Hire at least 100 net new employees for its Oak Ridge, Tennessee, facility
• Hire at least 175 net new employees for its Piketon, Ohio, facility up from
100 net new employee hires
The Company’s 2026 guidance is subject to a number of assumptions and
uncertainties that could affect results either positively or negatively.
Variations from these expectations could cause differences between this guidance
and the ultimate results. This includes the assumption of no significant change
in restrictions in our ability to receive and sell Russian LEU or other uranium
products, no significant economic disruptions or downturns, the successful
implementation of our planned expansion projects, and that current business
operations will continue on an ongoing basis.
About Centrus Energy Corp.
Centrus Energy is a trusted American supplier of nuclear fuel and services for
the nuclear power industry, helping meet the growing need for clean, affordable,
carbon-free energy. Since 1998, the Company has provided its utility customers
with more than 1,850 reactor years of fuel, which is equivalent to more than 7
billion tons of coal.
With world-class technical and engineering capabilities, Centrus is pioneering
production of High-Assay, Low-Enriched Uranium and is leading the effort to
restore America’s uranium enrichment capabilities at scale so that we can meet
our clean energy, energy security, and national security needs. Find out more at
www.centrusenergy.com or follow us on LinkedIn and X.
Forward-Looking Statements:
This news release contains “forward-looking statements” within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended, and the Private
Securities Litigation Reform Act of 1995. In this context, forward-looking
statements mean statements related to future events, which may impact our
expected future business and financial performance, and often contain words such
as “expects”, “anticipates”, “intends”, “plans”, “believes”, “will”, “should”,
“could”, “would” or “may” and other words of similar meaning. These forward-
looking statements are based on information available to us as of the date of
this news release and represent management’s current views and assumptions with
respect to future events and operational, economic and financial performance.
Forward-looking statements are not guarantees of future performance, events or
results and involve known and unknown risks, uncertainties and other factors,
which may be beyond our control and which may be exacerbated by any worsening of
the global business and economic environment including but not limited to, risks
and uncertainties related to the following:
• our ability to obtain a long-term extension of our existing lease for Piketon
from the DOE on acceptable terms or at all, including the potential need to
delay, scale back, or abandon our planned expansion of LEU and HALEU enrichment
capacity in Piketon and to recognize a significant non-cash charge relating to
capitalized improvements at Piketon;
• the war in Ukraine and other geopolitical conflicts, including the resulting
bans, laws, tariffs, sanctions or other government measures, and actions by
third parties, including contractual counterparties, as a result of such
conflicts that could directly or indirectly impact our ability to obtain,
deliver, transport, sell or collect payment for, LEU or the SWU and natural
uranium hexafluoride components of LEU;
• our reliance on third-party suppliers to provide essential products and
services to us;
• restrictions on imports and exports, including those imposed under the RSA,
and related to international trade legislation;
• our government contracts, including related to government shutdowns, changes
to the U.S. government’s appropriated funding levels for HALEU and the
government’s inability to satisfy its obligations;
• our receipt of additional task orders under the HALEU Production Contract, LEU
Production Contract and HALEU Deconversion Contract and, if awarded, the nature,
timing and amount thereof;
• our ability to obtain new contracts or funding to be able to continue
operations;
• whether or when government demand for HALEU or LEU for government or
commercial uses will materialize and at what level;
• the impact and potential extended duration of a supply/demand imbalance in the
market for LEU;
• significant competition from major LEU producers, including foreign
competitors, who may be less cost sensitive than we are;
• limitations on our ability to compete in foreign markets;
• pricing trends and demand in the uranium and enrichment markets, especially in
light of the potential of limited supply and our dependence on others for
deliveries of LEU;
• our ability to successfully implement our planned expansion projects in
Piketon, Ohio and Oak Ridge, Tennessee, including our ability to raise the
capital necessary for such projects;
• our ability to successfully integrate artificial intelligence technologies
into our operations;
• our ability to realize the anticipated benefits of acquisitions, including our
acquisition of Westerman, and risks associated with acquisitions, including
integration difficulties, unknown liabilities, additional costs and dilution;
• natural and other disasters;
• pandemics and other health crises;
• the fact that our revenue is largely dependent on our largest customers and
our sales backlog;
• our long-term liabilities, including our postretirement health and life
benefit obligations, our 0% Convertible Notes and our 2.25% Convertible Notes;
• failures or security, including cybersecurity, breaches of our information
technology systems; and
• the impact of, or changes to, government regulation and policies or
interpretation of laws or regulations, including by the SEC, DOE, DOC and the
NRC.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which apply only as of the date of this news release. These factors
may not constitute all factors that could cause actual results to differ from
those discussed in any forward-looking statement. Accordingly, forward-looking
statements should not be relied upon as a predictor of actual results. Readers
are urged to carefully review and consider the various disclosures made in this
news release and in our filings with the SEC, including our Annual Report on
Form 10-K for the year ended December 31, 2025, under Part II, Item 1A - “Risk
Factors” in our Quarterly report on Form 10-Q for the quarter ended March 31,
2026, under Part II, Item 1A - “Risk Factors” in our Quarterly report on Form
10-Q for the quarter ended June 30, 2026, and the Risk Factors in our Form S-3
Shelf Registration filed with the SEC on November 2, 2026, and our filings with
the SEC that attempt to advise interested parties of the risks and factors that
may affect our business. We do not undertake to update our forward-looking
statements to reflect events or circumstances that may arise after the date of
this news release, except as required by law.
Contacts:
Investors and Media: Neal Nagarajan at [email protected]
CENTRUS ENERGY CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(Unaudited; in millions, except share and per share data)
Thr… Nine
Mon… Mon…
End… End…
Sep… Sep…
30, 30,
R… 2026 20… 2026 20…
──────────────────────────────────────────────────────────────────────────────
S…
w… $ 14… $ 10.7 $ 15… $ 187…
u…
U… 17… 34.1 74… 34.1
T… 23… 30.1 78… 80.7
s…
T… 55… 74.9 30… 302…
r…
C…
of
S…
S…
w…
u… 38… 52.6 15… 147…
a…
u…
T… 27… 26.6 80… 72.3
s…
T…
c… 66… 79.2 23… 220…
of
s…
G…
(… -1… -4.3 70… 82.5
p…
A…
t… 4.7 1.7 34… 8.0
c…
S…
g… 13… 9.5 49… 31.2
a…
a…
A…
of 1.2 1.1 5.5 5.9
i…
a…
O…
(… -2… -16… -1… 37.4
i…
N…
c…
of
n… 1.0 1.0 3.0 2.9
p…
b…
l…
I… 3.9 3.4 12… 9.9
e…
I… -1… -12… -5… -28…
i…
E…
of — — — -11…
l…
d…
G…
on
c…
in
f… -4… — -4… —
v…
of
w…
l…
O…
(… — -0.1 0.2 —
e…
n…
I…
(…
b… 28… -8.0 62… 64.6
i…
t…
I…
t… -2… -11… 4.4 4.6
(…
e…
N…
i…
a… $ 31… $ 3.9 $ 58… $ 60.0
c…
i…
N…
i…
p…
s…
B… $ 1.… $ 0.21 $ 2.… $ 3.40
D… $ 1.… $ 0.19 $ 2.… $ 3.16
A…
n…
of
c…
s…
o…
(…
t…
B… 20,… 18… 20,… 17…
D… 22,… 20… 22,… 18…
CENTRUS ENERGY CORP.
NON-GAAP ADJUSTED OPERATING (LOSS) INCOME, ADJUSTED NET INCOME (LOSS) AND
ADJUSTED NET INCOME (LOSS) PER SHARE RECONCILIATION TABLE
The Company measures Operating (Loss) Income, Net Income and Net Income per
Share on a GAAP basis, on a normalized basis (“Normalized Operating (Loss)
Income”, “Normalized Net Income (Loss)” and “Normalized Net Income (Loss) per
Share”), and on an adjusted basis (“Adjusted Operating (Loss) Income”, “Adjusted
Net Income (Loss)” and “Adjusted Net Income (Loss) per Share”) to exclude (i)
the gain on the change of fair value of the warrant liability, (ii) short-term,
non-capitalizable costs related to the expansion of our operations in Piketon,
Ohio and Oak Ridge, Tennessee to scale up uranium enrichment operations (“Growth
Costs”) and (iii) stock-based compensation.
Normalized earnings exclude the revaluation of the Warrant Liability , which is
included as Gain on Change in Fair Value of Warrant Valuation on the Condensed
Consolidated Statements of Operations and Comprehensive Income. We are also
adjusting for the one-time expenses related to the issuance of the warrants,
which were included as Selling, General and Administrative expense on the
Condensed Consolidated Statements of Operations and Comprehensive Income.
Adjusted earnings further exclude Growth Costs and stock-based compensation.
Growth Costs relate to the initial phase of our expansion projects (e.g.
manufacturing readiness and the training and onboarding of new employees) and
are included as Advanced Technology Costs on the Condensed Consolidated
Statements of Operations and Comprehensive Income. The Company expects to stop
expensing Growth Costs as costs related to our expansion projects become
capitalizable. We incur expense related to stock-based compensation which are
included as Selling, General and Administrative expense on the Condensed
Consolidated Statements of Operations and Comprehensive Income.
We believe Adjusted Operating (Loss) Income, Adjusted Net Income (Loss) and
Adjusted Net Income (Loss) per Share, which are non-GAAP financial measures,
provide investors with additional understanding of the Company’s overall
financial performance as well as its strategic financial planning analysis and
period-to-period comparability. These metrics are useful to investors because
they reflect how management evaluates the Company’s ongoing operating
performance from period-to-period after removing certain transactions and
activities that affect comparability of the metrics and are not reflective of
the Company’s core operations.
Our calculation of Adjusted Operating (Loss) Income, Adjusted Net Income, and
Adjusted Net Income per Share may not be comparable to similarly named measures
reported by other companies.
The following tables present a reconciliation of the Operating (Loss) Income,
the most directly comparable GAAP measure, to Adjusted Operating (Loss) Income,
a reconciliation of the Net Income, the most directly comparable GAAP measure,
to Adjusted Net Income, and a reconciliation of the Net Income Per Share, the
most directly comparable GAAP measure, to Adjusted Net Income Per Share, for
each of the periods indicated:
Three Months Ended September 30, 2026 Compared with Three Months Ended September
30, 2025
T…
M…
E…
S…
3…
2…
──────────────────────────────────────────────────────────────────────────────
G… W… N… G… St… Ad…
(… C… Co… (N…
… $ -… $ — $ -… $ — $ — $ -…
…
…
… 4… — 4… -… — 2…
…
…
… 1… -… 8… — 1… 9…
…
…
…
… 1… — 1… — — 1…
…
…
… -… 4… -… 2… -… -…
…
…
…
…
… 1… — 1… — — 1…
…
…
…
… 3… — 3… — — 3…
…
… -… — -… — — -…
…
…
…
…
…
… -… 4… — — — —
…
…
…
…
…
…
… 2… -… -… 2… -… -…
…
…
…
… -… — -… 0… -… -…
…
…
…
…
… $ 3… $ -… $ -… $ 1… $ -… $ -…
…
…
…
…
…
…
…
…
… $ 1… $ -… $ -…
… $ 1… $ -… $ -…
…
…
…
…
…
…
…
…
… 2… 2… 20…
… 2… 2… 20…
T…
M…
E…
S…
3…
2…
──────────────────────────────────────────────────────────────────────────────
G… W… N… Gr… St… Ad…
(… Co… Co… (N…
… $ -… $ — $ -… $ — $ — $ -…
…
…
… 1… — 1… -… — 0…
…
…
… 9… — 9… — -… 8…
…
…
…
… 1… — 1… — — 1…
…
…
… -… — -… 1… 0… -…
…
…
…
…
… 1… — 1… — — 1…
…
…
…
… 3… — 3… — — 3…
…
… -… — -… — — -…
…
…
… -… — -… — — -…
…
…
… -… — -… 1… 0… -…
…
…
…
… -… — -… 0… 0… -…
…
…
…
… $ 3… $ — $ 3… $ 0… $ 0… $ 5…
…
…
…
…
…
…
… $ 0… $ 0… $ 0…
… $ 0… $ 0… $ 0…
…
…
…
…
…
…
…
…
… 1… 1… 18…
… 2… 2… 20…
Nine Months Ended September 30, 2026 Compared with Nine Months Ended September
30, 2025
N…
M…
E…
S…
3…
2…
──────────────────────────────────────────────────────────────────────────────
G… W… N… G… S… A…
(… C… C… (…
… $ 7… $ — $ 7… $ — $ — $ 70…
…
…
… 3… — 3… -3… — 4.4
…
…
… 4… -… 4… — -1… 28…
…
…
…
… 5… — 5… — — 5.5
…
…
…
… -… 4… -… 30… 16… 32…
…
…
…
…
… 3… — 3… — — 3.0
…
…
…
… 1… — 1… — — 12…
…
… -… — -… — — -5…
…
…
…
…
…
… -… 4… — — — —
…
…
…
…
…
… 0… — 0… — — 0.2
…
…
… 6… -… 2… 30… 16… 67…
…
…
…
… 4… — 4… 6.8 3.8 15…
…
…
…
… $ 5… $ -… $ 1… $ 23… $ 13… $ 52…
…
…
…
…
…
…
… $ 2… $ 0… $ 2.…
… $ 2… $ 0… $ 2.…
…
…
…
…
…
…
…
…
… 2… 2… 2…
… 2… 2… 2…
N…
M…
E…
S…
3…
2…
──────────────────────────────────────────────────────────────────────────────
G… W… N… Gr… St… Ad…
(… Co… Co… (N…
… $ 8… $ — $ 8… $ — $ — $ 8…
…
…
… 8… — 8… -… — 2…
…
…
… 3… — 3… — -… 2…
…
…
…
… 5… — 5… — — 5…
…
…
… 3… — 3… 5… 5… 4…
…
…
…
…
… 2… — 2… — — 2…
…
…
…
… 9… — 9… — — 9…
…
… -… — -… — — -…
…
…
… -… — -… — — -…
…
…
…
…
…
…
… — — — — — —
…
…
…
…
…
… — — — — — —
…
…
… 6… — 6… 5… 5… 7…
…
…
…
… 4… — 4… 1… 1… 7…
…
…
…
… $ 6… $ — $ 6… $ 4… $ 4… $ 6…
…
…
…
…
…
…
… $ 3… $ 3… $ 3…
… $ 3… $ 3… $ 3…
…
…
…
…
…
…
…
…
… 1… 1… 17…
… 1… 1… 18…
CENTRUS ENERGY CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; in millions)
Nine Months Ended
September 30,
OPERATING 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net income $ 58.4 $ 60.0
Adjustments to
reconcile net income
to
cash used in operating
activities:
Depreciation and 6.8 6.9
amortization
Gain on change in fair
value of warrant -46.4 —
liability
Deferred tax assets 4.2 3.6
Equity-related 16.8 5.3
compensation
Revaluation of -0.6 4.1
inventory borrowings
Gain on extinguishment — -11.8
of 8.25% Notes
Amortization of debt
issuance costs and 4.0 —
discount
Other reconciling 0.3 2.1
adjustments, net
Changes in operating
assets and
liabilities:
Accounts receivable 3.9 19.2
Inventories 106.9 -317.2
Inventories owed to
customers and -138.7 222.8
suppliers
Other current assets 0.3 0.2
Accounts payable and -8.1 -4.5
other liabilities
Payables under
inventory purchase 23.3 126.4
agreements
Deferred revenue and
advances from -37.4 -12.5
customers, net of
deferred costs
Pension and
postretirement benefit -4.5 -4.9
liabilities
Other changes, net -0.3 -0.3
Cash (used in)
provided by operating -11.1 99.4
activities
INVESTING
Capital expenditures -226.4 -10.1
Cash used in investing -226.4 -10.1
activities
FINANCING
Proceeds from the
issuance of common 53.9 139.7
stock, net
Proceeds from the
issuance of 0% — 782.4
Convertible Senior
Notes, net
Proceeds from the
issuance of common
stock, pre-funded 493.8 —
warrants, and common
warrants, net
Common stock withheld
for tax
obligations under -0.7 -2.9
stock-based
compensation plan
Payment of interest — -3.5
classified as debt
Payment of principal
to redeem 8.25% — -74.3
Notes
Cash provided by 547.0 841.4
financing activities
Effect of exchange
rate changes on cash, -0.2 -0.1
cash equivalents and
restricted cash
Increase in cash, cash
equivalents and 309.3 930.6
restricted cash
Cash, cash equivalents
and restricted 1,960.1 704.0
cash, beginning of
period
Cash, cash equivalents
and restricted $ 2,269.4 $ 1,634.6
cash, end of period
Nine Months Ended September
Supplemental cash flow 30,
disclosures: 2026 2025
──────────────────────────────────────────────────────────────────────────────
Cash paid for interest $ 4.5 $ 4.4
Cash paid for income taxes
Federal $ — $ —
State $ 0.4 $ 0.4
Foreign $ — $ —
Non-cash activities:
Adjustment of right to use
lease assets $ 0.5 $ 1.3
from lease modification
Property, plant and
equipment included
in accounts payable and $ 60.2 $ 2.2
accrued
liabilities
Equity issuance costs
included in $ 0.4 $ —
accounts payable and
accrued liabilities
Reclassification of
equity-based $ 0.8 $ —
compensation from equity
to liability
CENTRUS ENERGY CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited; in millions, except share and per share data)
September 30, December 31,
2026 2025
──────────────────────────────────────────────────────────────────────────────
ASSETS
Current assets:
Cash and cash equivalents $ 2,236.1 $ 1,957.2
Accounts receivable 26.8 30.7
Inventories 177.7 322.9
Deferred costs associated with
deferred 33.2 40.9
revenue
Other current assets 11.7 11.9
Total current assets 2,485.5 2,363.6
Property, plant and equipment, net of
accumulated depreciation of $7.9
million 312.9 29.5
and $6.7 million as of September 30,
2026 and December 31, 2025,
respectively
Deposits for financial assurance 33.1 2.7
Intangible assets, net 15.7 21.2
Deferred tax assets 17.7 21.9
Other long-term assets 6.7 7.0
Total assets $ 2,871.6 $ 2,445.9
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued $ 107.6 $ 41.6
liabilities
Payables under inventory purchase 41.8 18.5
agreements
Inventories owed to customers and 54.0 192.7
suppliers
Deferred revenue and advances from 85.3 131.1
customers, current
Short-term inventory loans — 38.9
Current debt — —
Total current liabilities 288.7 422.8
Long-term debt 1,178.8 1,174.8
Warrant liability 220.4 —
Postretirement health and life
benefit 68.1 72.2
obligations
Pension benefit liabilities 2.9 3.0
Deferred revenue and advances from 0.7 —
customers, noncurrent
Other long-term liabilities 6.9 8.0
Total liabilities 1,766.5 1,680.8
Stockholders’ equity:
Preferred stock, par value $1.00 per
share, 20,000,000 shares authorized
Series A Participating Cumulative — —
Preferred Stock, none issued
Class A Common Stock, par value $0.10
per share, 70,000,000 shares
authorized,
19,733,908 and 18,945,365 shares 2.0 1.9
issued
and outstanding as of September 30,
2026
and December 31, 2025, respectively
Class B Common Stock, par value $0.10
per share, 30,000,000 shares
authorized,
719,200 shares issued and outstanding 0.1 0.1
as
of September 30, 2026 and December
31,
2025, respectively
Excess of capital over par value 1,044.0 762.3
Retained earnings 59.9 1.5
Accumulated other comprehensive loss -0.9 -0.7
Total stockholders’ equity 1,105.1 765.1
Total liabilities and stockholders’ $ 2,871.6 $ 2,445.9
equity